Seeing Is Believing
Currently out of the existing stock ratings of Chris Schott, 7 are a SELL (4.35%), 37 are a HOLD (22.98%), 117 are a BUY (72.67%).
Analyst Chris Schott works at JPMORGAN with a stock forecast success ratio of 44.25% fulfilled within 262.93 days on average.
Chris Schott’s has documented 336 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 01-May-2024.
Analyst best performing recommendations are on EQRX (EQRX).
The best stock recommendation documented was for EQRX (EQRX) at 8/16/2022. The price target of $5.5 was fulfilled within 3 days with a profit of $0.67 (13.87%) receiving and performance score of 46.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
187
$24.27 (14.91%)
195
8 days ago
10/13 (76.92%)
$27.38 (17.15%)
191
Buy
189
$26.27 (16.14%)
181
3 months 1 days ago
9/11 (81.82%)
$15.71 (9.07%)
252
Buy
195
$32.27 (19.83%)
180
3 months 1 days ago
9/10 (90%)
$21.71 (12.53%)
445
Hold
165
$2.27 (1.39%)
157
3 months 20 days ago
11/11 (100%)
$2.96 (1.83%)
314
Buy
180
$17.27 (10.61%)
195
4 months 4 days ago
3/5 (60%)
$21.06 (13.25%)
496
Which stock is Chris Schott is most bullish on?
Which stock is Chris Schott is most reserved on?
What Year was the first public recommendation made by Chris Schott?